Organon & Co. (OGN)
13.40
+0.04
(+0.30%)
USD |
NYSE |
May 15, 16:00
13.38
-0.02
(-0.15%)
After-Hours: 20:00
Organon Free Cash Flow : 708.00M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 14.12B |
| Eli Lilly & Co. | 10.37B |
| Ligand Pharmaceuticals, Inc. | 114.06M |
| Veradermics, Inc. | -- |
| Johnson & Johnson | 17.80B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 225.00M |
| Cash from Investing (Quarterly) | 386.00M |
| Cash from Financing (Quarterly) | -38.00M |
| Free Cash Flow Per Share (Quarterly) | 0.6771 |
| Free Cash Flow to Equity (Quarterly) | 409.00M |
| Free Cash Flow to Firm (Quarterly) | 255.46M |
| Free Cash Flow Yield | 20.25% |